Presentation is loading. Please wait.

Presentation is loading. Please wait.

Puja Gaur, MD, Wayne L. Hofstetter, MD, B

Published byJulia Maier Modified over 6 years ago

Similar presentations

Presentation on theme: "Puja Gaur, MD, Wayne L. Hofstetter, MD, B"— Presentation transcript:

1 Comparison Between Established and the Worldwide Esophageal Cancer Collaboration Staging Systems 
Puja Gaur, MD, Wayne L. Hofstetter, MD, B. Nebiyou Bekele, PhD, Arlene M. Correa, PhD, Reza J. Mehran, MD, David C. Rice, MD, Jack A. Roth, MD, Ara A. Vaporciyan, MD, Thomas W. Rice, MD, Stephen G. Swisher, MD  The Annals of Thoracic Surgery  Volume 89, Issue 6, Pages e3 (June 2010) DOI: /j.athoracsur Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Kaplan-Meier curves using the different staging systems illustrate the Worldwide Esophageal Cancer Collaboration (WECC) staging system to be relatively superior in predicting survival of all patients with gastroesophageal junction adenocarcinoma (A) as well as for the subgroup of patients who underwent surgical resection alone (B). The Annals of Thoracic Surgery  , e3DOI: ( /j.athoracsur ) Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Puja Gaur, MD, Wayne L. Hofstetter, MD, B"

Similar presentations

Differential Response to Preoperative Chemoradiation and Surgery in Esophageal Adenocarcinomas Based on Presence of Barrett's Esophagus and Symptomatic.

Differential Response to Preoperative Chemoradiation and Surgery in Esophageal Adenocarcinomas Based on Presence of Barrett's Esophagus and Symptomatic.
The evolution of treatment outcomes for resected stage IIIA non–small cell lung cancer over 16 years at a single institution  Linda W. Martin, MD, Arlene.

The evolution of treatment outcomes for resected stage IIIA non–small cell lung cancer over 16 years at a single institution  Linda W. Martin, MD, Arlene.
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience  Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,

Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience  Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Evaluation of the Reliability of Clinical Staging of T2 N0 Esophageal Cancer: A Review of The Society of Thoracic Surgeons Database  Traves D. Crabtree,

Evaluation of the Reliability of Clinical Staging of T2 N0 Esophageal Cancer: A Review of The Society of Thoracic Surgeons Database  Traves D. Crabtree,
Outcomes of Reintervention on the Autograft After Ross Procedure

Outcomes of Reintervention on the Autograft After Ross Procedure
Association of Perioperative Fluid Balance and Adverse Surgical Outcomes in Esophageal Cancer and Esophagogastric Junction Cancer  Shenhai Wei, MD, PhD,

Association of Perioperative Fluid Balance and Adverse Surgical Outcomes in Esophageal Cancer and Esophagogastric Junction Cancer  Shenhai Wei, MD, PhD,
Utility of PET, CT, and EUS to Identify Pathologic Responders in Esophageal Cancer  Stephen G. Swisher, MD, Mary Maish, MD, Jeremy J. Erasmus, MD, Arlene.

Utility of PET, CT, and EUS to Identify Pathologic Responders in Esophageal Cancer  Stephen G. Swisher, MD, Mary Maish, MD, Jeremy J. Erasmus, MD, Arlene.
Joshua E. Rosen, BASc, Hari B

Joshua E. Rosen, BASc, Hari B
Neoadjuvant chemoradiotherapy followed by surgery for esophageal adenocarcinoma: Significance of microscopically positive circumferential radial margins 

Neoadjuvant chemoradiotherapy followed by surgery for esophageal adenocarcinoma: Significance of microscopically positive circumferential radial margins 
Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis

Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer  Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.

Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer  Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.
Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population  Edmund S. Kassis, MD, Ara A. Vaporciyan,

Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population  Edmund S. Kassis, MD, Ara A. Vaporciyan,
Biventricular Conversion After Single Ventricle Palliation in Patients With Small Left Heart Structures: Short-Term Outcomes  Brian T. Kalish, MD, Puja.

Biventricular Conversion After Single Ventricle Palliation in Patients With Small Left Heart Structures: Short-Term Outcomes  Brian T. Kalish, MD, Puja.
Super-Charged Pedicled Jejunal Interposition Performance Compares Favorably With a Gastric Conduit After Esophagectomy  Elizabeth H. Stephens, MD, PhD,

Super-Charged Pedicled Jejunal Interposition Performance Compares Favorably With a Gastric Conduit After Esophagectomy  Elizabeth H. Stephens, MD, PhD,
Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy  Apar Pataer, MD, PhD, Neda Kalhor,

Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy  Apar Pataer, MD, PhD, Neda Kalhor,
Non-Small Cell Lung Cancer Resection in Lymphoma Patients

Non-Small Cell Lung Cancer Resection in Lymphoma Patients
Castigliano M. Bhamidipati, DO, MS, George J

Castigliano M. Bhamidipati, DO, MS, George J

Similar presentations

Ads by Google